Embolization of brain arteriovenous malformations (AVMs) prior to stereotactic radiosurgery (SRS) has been reported to negatively affect obliteration rates. The goal of this systematic review and meta-analysis was to compare the outcomes of AVMs treated with embolization plus SRS (E+SRS group) and those of AVMs treated with SRS alone (SRS group).
A literature review was performed using PubMed to identify studies with 10 or more AVM patients and obliteration data for both E+SRS and SRS groups. A meta-analysis was performed to compare obliteration rates between the E+SRS and SRS groups.
Twelve articles comprising 1716 patients were eligible for analysis. Among the patients with radiological follow-up data, complete obliteration was achieved in 48.4% of patients (330/681) in the E+SRS group compared with 62.7% of patients (613/978) in the SRS group. A meta-analysis of the pooled data revealed that the obliteration rate was significantly lower in the E+SRS group (OR 0.51, 95% CI 0.41–0.64, p < 0.00001). Symptomatic adverse radiation effects were observed in 6.6% (27/412 patients) and 11.1% (48/433 patients) of the E+SRS and SRS groups, respectively. The annual post-SRS hemorrhage rate was 2.0%–6.5% and 0%–2.0% for the E+SRS and SRS groups, respectively. The rates of permanent morbidity were 0%–6.7% and 0%–13.5% for the E+SRS and SRS groups, respectively.
Arteriovenous malformation treatment with combined embolization and SRS is associated with lower obliteration rates than those with SRS treatment alone. However, this comparison does not fully account for differences in the initial AVM characteristics in the E+SRS group as compared with those in the SRS group. Further studies are warranted to address these limitations.
AkakinAOzkanAAkgunEKocDYKonyaDPamirMN: Endovascular treatment increases but Gamma Knife radiosurgery decreases angiogenic activity of arteriovenous malformations: an in vivo experimental study using a rat cornea model. Neurosurgery66:121–1302010
BackAGVollmerDZeckOShkedyCSheddenPM: Retrospective analysis of unstaged and staged Gamma Knife surgery with and without preceding embolization for the treatment of arteriovenous malformations. J Neurosurg109Suppl:57–642008
BaranoskiJFGrantRAHirschLJVisintainerPGerrardJLGünelM: Seizure control for intracranial arteriovenous malformations is directly related to treatment modality: a meta-analysis. J Neurointerv Surg6:684–6902014
BlackburnSLAshleyWWJrRichKMSimpsonJRDrzymalaRERayWZ: Combined endovascular embolization and stereotactic radiosurgery in the treatment of large arteriovenous malformations. J Neurosurg114:1758–17672011
CrowleyRWDucruetAFKalaniMYSKimLJAlbuquerqueFCMcDougallCG: Neurological morbidity and mortality associated with the endovascular treatment of cerebral arteriovenous malformations before and during the Onyx era. J Neurosurg122:1492–14972015
DalyaiRTheofanisTStarkeRMChalouhiNGhobrialGJabbourP: Stereotactic radiosurgery with neoadjuvant embolization of larger arteriovenous malformations: an institutional experience. BioMed Res Int2014:3065182014
Del ValleRZentenoMJaramilloJLeeADe AndaS: Definition of the key target volume in radiosurgical management of arteriovenous malformations: a new dynamic concept based on angiographic circulation time. J Neurosurg109Suppl:41–502008
DingDLiuKC: Predictive capability of the Spetzler-Martin versus Supplementary Grading Scale for microsurgical outcomes of cerebellar arteriovenous malformations. J Cerebrovasc Endovasc Neurosurg15:307–3102013
DingDStarkeRMKanoHMathieuDHuangPKondziolkaD: Radiosurgery for cerebral arteriovenous malformations in A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA)–eligible patients: a multicenter study. Stroke47:342–3492016
IzawaMChernovMHayashiMIsekiHHoriTTakakuraK: Combined management of intracranial arteriovenous malformations with embolization and Gamma Knife radiosurgery: comparative evaluation of the long-term results. Surg Neurol71:43–532009
KanoHKondziolkaDFlickingerJCParkKJParryPVYangHC: Stereotactic radiosurgery for arteriovenous malformations, Part 6: multistaged volumetric management of large arteriovenous malformations. J Neurosurg116:54–652012
KimHAblaAANelsonJMcCullochCEBerviniDMorganMK: Validation of the supplemented Spetzler-Martin grading system for brain arteriovenous malformations in a multicenter cohort of 1009 surgical patients. Neurosurgery76:25–332015
MohrJPParidesMKStapfCMoqueteEMoyCSOverbeyJR: Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet383:614–6212014
MorgensternLBHemphillJCIIIAndersonCBeckerKBroderickJPConnollyESJr: Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke41:2108–21292010
MurrayGBrauRH: A 10-year experience of radiosurgical treatment for cerebral arteriovenous malformations: a perspective from a series with large malformations. Clinical article. J Neurosurg115:337–3462011
NatarajanSKGhodkeBBritzGWBornDESekharLN: Multimodality treatment of brain arteriovenous malformations with microsurgery after embolization with Onyx: single-center experience and technical nuances. Neurosurgery62:1213–12262008
ShtrausNSchifterDCornBWMaimonSAlaniSFrolovV: Radiosurgical treatment planning of AVM following embolization with Onyx: possible dosage error in treatment planning can be averted. J Neurooncol98:271–2762010
StarkeRMKomotarRJHwangBYFischerLEOttenMLMerkowMB: A comprehensive review of radiosurgery for cerebral arteriovenous malformations: outcomes, predictive factors, and grading scales. Stereotact Funct Neurosurg86:191–1992008